Rani Therapeutics Holdings Inc - Ordinary Shares Class A

+0.28 (+1.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)398.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.63 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$19.68
50-Day MA$18.81
200-Day MAN/A
See more pivots

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock, NASDAQ:RANI

2051 Ringwood Avenue, San Jose, California 95131
United States of America
Phone: +1.408.457.3700
Number of Employees:


Rani Therapeutics Holdings, Inc. operates as a clinical stage bio-therapeutics company providing technologies to enable the development of orally administered biologics. It offers RaniPill capsule, an orally ingestible pill for the administration of a broad range of biologics. The company was founded by Mir Imran on April 6, 2021 and is headquartered in San Jose, CA.